Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

EMBI
Emerald Bioscience, Inc. Common Stock
stock OTC

Inactive
Jan 28, 2021
0.0698USD-11.757%(-0.0093)4,843,892
Pre-market
0.00USD-100.000%(-0.08)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Mar 8, 2021
08:47AM EST  Skye Bioscience Appoints Cannabinoid Science Experts Giovanni   GlobeNewswire Inc
Mar 3, 2021
08:38AM EST  Skye Bioscience to Present at H.C. Wainwright Global Life Sciences   GlobeNewswire Inc
Feb 3, 2021
09:10AM EST  Skye Bioscience to Participate in Investment Conferences in February   GlobeNewswire Inc
Jan 28, 2021
08:35AM EST  Live Investor Conference & Webinar: Small and Microcap Company Showcase on   PR Newswire
Jan 19, 2021
08:30AM EST  Emerald Bioscience Launches Rebrand Including Name Change to Skye   GlobeNewswire Inc
Jan 15, 2021
01:30PM EST  Emerald Bioscience to Change Name and Trading Symbol Effective   GlobeNewswire Inc
Jan 11, 2021
08:35AM EST  Cannabis Virtual Investor Conference Presentations Now Available for On-Demand   PR Newswire
Jan 6, 2021
10:22AM EST  Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids   Benzinga
Jan 5, 2021
08:36AM EST  Live Investor Conference & Webinar: Cannabis Industry Companies Present January   PR Newswire
08:30AM EST  Emerald Bioscience to Present at the KCSA Cannabis Investor Conference   GlobeNewswire Inc
Dec 16, 2020
08:30AM EST  Drug Delivery and Translational Research article highlights significantly better drug load and duration of activity of prodrug of THC compared to leading commercial drugs for treating glaucoma   GlobeNewswire Inc
Dec 7, 2020
08:45AM EST  Emerald Bioscience to Present at the Benzinga Global Small Cap   GlobeNewswire Inc
Dec 5, 2020
09:01AM EST  Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids   Benzinga
Sep 30, 2020
08:30AM EDT  Renewed team and capital focused on advancing lead compound for glaucoma into human studies   GlobeNewswire Inc
Sep 3, 2020
11:40AM EDT  Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual   GlobeNewswire Inc
Aug 13, 2020
08:30AM EDT  Emerald Bioscience Appoints Biotech Veteran Dr. Margaret   GlobeNewswire Inc
Aug 10, 2020
08:30AM EDT  Renewed team and capital focused on advancing lead compound for glaucoma into clinical development   GlobeNewswire Inc
Jul 31, 2020
09:20AM EDT  Emerald Bioscience Announces Pricing of $7.0 Million Upsized   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC